Vijay Kamal Ahuja

Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious <i>in Vivo</i>

Pravin S. Shirude, Radha Krishan Shandil, C Sadler et al. · Journal of Medicinal Chemistry · 2013 · 161 citations

Pharmacotherapy, Antimicrobial Chemotherapy, Pharmaceutical Chemistry +22

Targeting redox heterogeneity to counteract drug tolerance in replicating <i>Mycobacterium tuberculosis</i>

Richa Mishra, Sakshi Kohli, Nitish Malhotra et al. · Science Translational Medicine · 2019 · 114 citations · Full text

<i>In Vitro</i> and <i>In Vivo</i> Efficacy of β-Lactams against Replicating and Slowly Growing/Nonreplicating Mycobacterium tuberculosis

Suresh Solapure, Neela Dinesh, Radha Krishan Shandil et al. · Antimicrobial Agents and Chemotherapy · 2013 · 80 citations · Full text

Microbial Pathogens, Tuberculosis Prevention, Strain Ss18b +18

Thiazolopyridine Ureas as Novel Antitubercular Agents Acting through Inhibition of DNA Gyrase B

Manoj Kale, Anandkumar Raichurkar, Shahul Hameed P et al. · Journal of Medicinal Chemistry · 2013 · 66 citations · Full text

Antiparasitic Agent, Molecular Biology, Antimicrobial Chemotherapy +21

Thiazolopyridone ureas as DNA gyrase B inhibitors: Optimization of antitubercular activity and efficacy

Ramesh R. Kale, Manoj Kale, David Waterson et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 41 citations · Full text

Medicinal Chemistry, Antitubercular Activity, Biochemistry +11